News & Information

PCDC EDRN-APaCC Joint (Virtual) Meeting

POSTED: November 9, 2021

The National Cancer Institute’s Pancreatic Cancer Detection Consortium (PCDC) and Early Detection Research Network – Alliance of Pancreatic Cancer Consortia for Early Detection (EDRN-APaCC) Joint Meeting (Virtual) took place on December 13, 2021 from 10:30a.m.-5:30p.m. ET.

View the Agenda

Could A Diabetes Diagnosis Help Detect Pancreatic Cancer Early?

POSTED: July 7, 2021

Bob Aronson was only 54 years old and, in the words of his son Tom, “extremely healthy.” “So it was really surprising to everyone when he went in for an annual routine eye exam and his eye doctor suspected diabetes,” Tom recalled.

Read the NCI Cancer Currents blog

The Search for Early Detection of Pancreatic Cancer Accelerates with Biomarkers

A 3D illustration of a human pancreas cancer cell.
POSTED: April 27, 2021

Scientists have identified more than 1,000 potential new biomarkers for cancer that they hope will aid in the early detection of many of these complex diseases, including one of the most challenging, pancreatic cancer.

Read the DCP Cancer Prevention Science blog

Pancreatic Cysts Are Monitored in New Trial Aimed at Reducing Cancer Risk Through Targeted Screening

An MRI of a pancreas with cysts presenting.
POSTED: April 8, 2021

In a new NCI-sponsored study now recruiting participants, investigators will evaluate two different screening strategies for non-cancerous pancreatic cysts to determine which works best at detecting early malignancy.

Read the DCP Cancer Prevention Science blog

New Onset Diabetes Cohort Sought to Unravel Complexities of Pancreatic Cancer Development

Pancreatic Cancer New Onset Diabetes: About 1 in 100 people with new onset diabetes are diagnosed with pancreatic cancer within 3 years of the diabetes diagnosis; 1 in 4 people diagnosed with pancreatic cancer were first diagnosed with diabetes.
POSTED: November 19, 2019

The National Cancer Institute is leading a project to create a cohort of people who are newly diagnosed with diabetes in the hopes that this group, who are at increased risk of developing pancreatic cancer, provide the clues in their blood and tissues to unravel some of the unknowns about this highly fatal cancer.

Read the DCP Cancer Prevention Science blog